About 300 million people worldwide experience depression. Many symptoms underline their experience, with disturbed sleep being a common pattern. However, not enough research goes into unearthing if people with sleep disorders are suffering from more than just that. That’s where mental health tech company Medibio Limited (ASX: MEB) comes in. The Company has achieved a
Read More
Whether you’re running for the train, or running from a lion, cortisol- the stress hormone, plays an important role in making sure you aren’t late, or eaten. Except, too much cortisol has detrimental effects to the brain and our health, with research suggesting that cortisol dysregulation can affect cognitive function and harm brain cells in
Read More
There’s no doubt that we are living in extraordinary times. The COVID-19 pandemic has tested almost every aspect of our lives, our resilience, ability to organise and ability to adapt. With a drastic change in our way of living, the toll on our collective mental health has been profound. Beyond Blue estimates that over 3
Read More
With mental health issues continuing to make headlines as greater importance is placed on its value towards wellbeing, medtech company Medibio (ASX: MEB) is developing a Software Medical Device for early detection of depressive symptoms. Sleep disorders, their onset, and progression, will be the key depressive symptom being targeted by Medibio’s technology which will be
Read More